Biohaven Book Value Per Share Growth & History (BHVN)
Biohaven's book value per share was $0.39 for fiscal 2025.
View full Biohaven company overviewBiohaven annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0.39 | -$3.79 | −90.62% |
| 2024 | 2024-12-31 | $4.18 | -$1.09 | −20.71% |
| 2023 | 2023-12-31 | $5.28 | -$2.62 | −33.22% |
| 2022 | 2022-12-31 | $7.90 | $7.02 | +796.80% |
| 2021 | 2021-12-31 | $0.88 | $0.45 | +106.73% |
| 2020 | 2020-12-31 | $0.43 | — | — |
Biohaven quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0.08 | -$1.19 | −93.64% |
| Q1 2026 | 2026-03-31 | $0.86 | -$1.68 | −66.14% |
| Q4 2025 | 2025-12-31 | $0.39 | -$3.79 | −90.62% |
| Q3 2025 | 2025-09-30 | -$0.16 | -$3.49 | — |
| Q2 2025 | 2025-06-30 | $1.27 | -$2.88 | −69.38% |
| Q1 2025 | 2025-03-31 | $2.54 | -$1.14 | −31.03% |
| Q4 2024 | 2024-12-31 | $4.18 | -$1.09 | −20.71% |
| Q3 2024 | 2024-09-30 | $3.33 | -$0.91 | −21.50% |
| Q2 2024 | 2024-06-30 | $4.16 | -$1.51 | −26.69% |
| Q1 2024 | 2024-03-31 | $3.68 | -$3.24 | −46.78% |
| Q4 2023 | 2023-12-31 | $5.28 | -$2.62 | −33.22% |
| Q3 2023 | 2023-09-30 | $4.24 | -$1,002,155.76 | −100.00% |
| Q2 2023 | 2023-06-30 | $5.67 | — | — |
| Q1 2023 | 2023-03-31 | $6.92 | — | — |
| Q4 2022 | 2022-12-31 | $7.90 | — | — |
| Q3 2022 | 2022-09-30 | $1,002,160.00 | — | — |
Biohaven book value per share trends
Over the last five fiscal years, Biohaven's book value per share decreased from $0.43 to $0.39, a change of -$0.03. The latest reported quarter, Q2 2026, shows $0.08.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biohaven source filings ↗